BKI
Asset Logo

BKI Investment Portfolio

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💰 Dividends

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-0.18%
Annual Growth

5 years average annual growth

💰

4.60%
Annual dividend yield

Based on the most recent dividend

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

121
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

BKI Investment Company Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales and currently employs 0 full-time employees. The company went IPO on 2003-12-12. BKI Investment Company Limited is an Australia-based investment company. The firm is primarily focused on long-term investment in Australian Securities Exchange (ASX) listed securities. The firm focuses on generating an increasing income stream for distribution to shareholders in the form of fully franked dividends to the extent of available imputation tax credits, through long-term investment in a portfolio of assets that are also able to deliver long term capital growth to shareholders. Its investment strategy is focused on research-driven, active equities management, investing for the long term, in profitable companies, with a history of paying attractive dividend yields. The firm's portfolio includes sectors, such as financials, materials, energy, consumer discretionary, utilities, industrials, consumer staples, telecommunication, healthcare and property. Its investment manager is Contact Asset Management Pty Limited.

📈 Performance

Price History

+5.81%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💰 Dividends

Payouts

💰 Annual Dividend Yield*

4.60%

💰 Annual Dividend Earnings Per $1,000 invested**

$46.04

💰 Most Recent Dividend Franked Percentage Estimate

100.00%

💰 Average Dividend Franked Percentage Estimate

100.00 %

💰 Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Estimate your dividend

If you held

$

of BKI, your last dividend payment(s) would have been:

$ 328.41

on Thu Aug 29 2024

$ 303.87

on Tue Feb 27 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2024

$0.08

100.00%

2023

$0.08

100.00%

2022

$0.07

100.00%

2021

$0.05

100.00%

2020

$0.06

100.00%

2019

$0.07

100.00%

2018

$0.07

100.00%

2017

$0.07

100.00%

2016

$0.07

100.00%

2015

$0.07

50.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$1.68

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in BKI

121

📊 Total Capital Earnings

$2M

🔃 Average investment frequency

38 weeks

💵 Average investment amount

$3,012

Last time a customer invested in BKI

6 hours
BKI investor breakdown
💵 Income of investors

More than 200k

150k - 200k

7%

100k - 150k

21%

50k - 100k

36%

Less than 50k

30%
👶 Age of investors

18 - 25

26 - 34

26%

35 - 90

69%
🙋 Legal gender of investors

Female

53%

Male

47%

Pearlers who invest in BKI also invest in...

Argo Investment Portfolio

ARG

Argo Investments Ltd is a AU-based company operating in industry. The company is headquartered in Adelaide, South Australia. Argo Investments Limited is an Australia-based listed investment company (LIC). The firm manages a diversified portfolio of Australian shares with an internally managed business model. The principal activities of the Company include the investment of funds in Australian listed securities and short-term interest-bearing securities. Its investment objective is to maximize long-term shareholder returns through reliable fully franked dividend income and capital growth. Its investment portfolio comprises approximately 90 Australian companies from across a range of industries. Its portfolio includes investments in various sectors, such as materials, other financials, banks, healthcare, consumer staples, industrials, energy, consumer discretionary, property, utilities, listed investment companies, and others. Its subsidiary, Argo Service Company Pty Ltd, is engaged in providing investment management and administration operations for the Company.

🙌 Performance (5Yr p.a)

0.25%

📊 Share price

$8.81 AUD
Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

3.21%

📊 Share price

$100.33 AUD

🇦🇺 AUSTRALIA

⛳️ DIVERSIFIED

🧱 MATERIALS

💸 FINANCIALS

Australian Foundation Investment Company Ltd is a AU-based company operating in industry. The company is headquartered in Melbourne, Victoria. Australian Foundation Investment Company Limited is an investment company, which is focused on investing in Australian and New Zealand equities. Its investment objective is to pay a stable to growing dividend over time and to provide attractive total returns over the medium to long term. The company has two portfolios of securities: the investment portfolio and the trading portfolio. The investment portfolio holds securities which the Company intends to retain on a long-term basis and includes a small sub-component over which options may be written and an additional small sub-component of international (non-Australian/New Zealand listed) stocks. The trading portfolio consist of securities that are held for short term trading only, including call option contracts written over securities that are held in the specific sub-component of the investment portfolio and on occasion put options, and is relatively small in size. Its investment sectors include banks, industrials, healthcare, and others.

🙌 Performance (5Yr p.a)

0.97%

📊 Share price

$7.36 AUD

Whitefield Industrials Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales. Whitefield Industrials Limited is an Australia-based investment company holding a diversified portfolio of Australian Securities Exchange (ASX) listed Industrial (non-resource) shares. The firm's principal activity is to invests in companies and trusts listed on the ASX. The firm's return objective includes a reliable stream of franked income; risk adjusted return higher than average of peer group, and portfolio return 0-100 basis points above the benchmark (S&P/ASX200 Industrials Accumulation) over rolling five-year periods. Its risk objective is to have a lower degree of variation against benchmark (target 0.7% - 1.0% tracking error). The company invests in various sectors, such as banks, health care, consumer discretionary, non-bank financials, industrials, real estate, consumer staples, communication services, information technology, materials and utilities. The firm's investment manager is Whitefield Capital Management Pty Ltd.

🙌 Performance (5Yr p.a)

1.40%

📊 Share price

$5.52 AUD

💰 HIGH DIVIDEND

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

13.60%

📊 Share price

$138.43 AUD

⛳️ DIVERSIFIED

📈 HIGH PRICE GROWTH

🌏 GLOBAL

🤖 TECHNOLOGY

Want more shares? Try these...

Black Rock Mining Ltd. is an exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-12-10. Its segments include Graphite and Corporate. The firm has an 84% interest in the Mahenge Graphite Project (Mahenge) located in Tanzania. The Project has a joint ore reserves committee (JORC) compliant mineral resource estimate of approximately 213m tons. The company also has ore reserves of approximately 70m tons. The Mahenge Project is spread across 324 square kilometers of exploration tenements in Tanzania’s Ulanga district, approximately 250 km north of the border with Mozambique. The Mahenge Project is also located approximately 250 kilometers west of the coastal port city of Mtwara on the Indian Ocean and 300 kilometers southwest of Tanzania’s city, Dar es Salaam. Its subsidiaries include Mahenge Resources Limited and Faru Grahite Corporation Limited.

🙌 Performance (5Yr p.a)

-6.59%

📊 Share price

$0.03 AUD

⛏️ MINING

Brickworks Ltd. engages in the manufacture and distribution of building products. The company is headquartered in Sydney, New South Wales and currently employs 1,850 full-time employees. Its segments include Building Products Australia, Building Products North America, Property and Investments. Building Products Australia and Building Products North America segments manufacture and supply vitrified clay and concrete products used in the building industry. Building Products Australia segment includes Austral Bricks (bricks producer) and other brands such as Austral Masonry and Bristile Roofing. Building Products North America segment includes the flagship brand of Glen-Gery. This segment's product lines include bricks, masonry blocks and accessories. Property segment utilizes opportunities associated with land owned by the Company, including the sale of property and investment in Property Trusts. Investments segment holds investments in the Australian share market, both for dividend income and capital growth, and includes the investment in Washington H. Soul Pattinson and Company Limited, and FBR Limited.

🙌 Performance (5Yr p.a)

7.10%

📊 Share price

$25.80 AUD

👷‍♀️ CONSTRUCTION

📈 HIGH PRICE GROWTH

Bisalloy Steel Group Ltd. engages in the production and sale of bisalloy quenched and tempered steel plate. The company is headquartered in Wollongong, New South Wales. The company went IPO on 2003-06-23. The Company’s products are used in the mining, construction, general fabrication and defense sectors. The firm operates through two geographic segments: Australia and Overseas. The Australian operations comprise of Bisalloy Steels Pty Limited and Bisalloy Steel Group Limited. Bisalloy Steels Pty Limited manufactures and sells wear-grade and high tensile plate through distributors and directly to original equipment manufacturers in both Australia and Overseas. The Overseas operations comprise of PT Bima Bisalloy and Bisalloy (Thailand) Co Limited located in Indonesia and Thailand respectively. These businesses distribute Bisalloy Q&T plate as well as other plate products. The company has a distribution network across Australasia, Indonesia, Thailand, the People’s Republic of China and the United Arab Emirates.

🙌 Performance (5Yr p.a)

57.86%

📊 Share price

$4.36 AUD

💰 HIGH DIVIDEND

⛏️ MINING

Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. The company is headquartered in North Ryde, New South Wales. The company went IPO on 2001-01-24. The firm is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.

🙌 Performance (5Yr p.a)

-13.62%

📊 Share price

$0.02 AUD

🧬 BIOTECHNOLOGY

Compare
Add to watchlist